← Insider buys
ALRN

Aileron Therapeutics, Inc.

Novartis Bioventures Ltd sold $133K of Aileron Therapeutics, Inc.

10% owner

Sold$132,927
$4.25Price
31,300Shares
−1%Stake

What ALRN did after the filing

Prices for ALRN after this filing aren't in yet.

Traded Mon, Jul 23. Filed Wed, Jul 25, 12:35 PM ET, during the session. Not investment advice.